52: Unraveling the Complexity of Commercializing Cell and Gene Therapies w/ Wajiha Ali - Part 2

Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation - A podcast by David Brühlmann - CMC Development Leader, Biotech C-level Advisor, Business Strategist

Send us a textDoes the process of commercializing cell and gene therapies seem complex and unclear to you?Dive deep into the groundbreaking world of cell and gene therapies with our guest, Wajiha Ali, a strategy expert who believes in bridging the gap between research and commercialization with data, as we unravel the complexities of bringing life-saving therapies to patients.From cutting-edge technologies to innovative collaboration models, we explore the future landscape of these transforma...